human
coronavirus
hcv
two
serogroup
repres
import
caus
upper
respiratori
tract
infect
report
human
aminopeptidas
n
cellsurfac
metalloproteas
intestin
lung
kidney
epitheli
receptor
human
coronaviru
strain
monoclon
antibodi
rb
block
viru
infect
human
lung
fibroblast
immunoprecipit
aminopeptidas
n
inhibit
enzymat
activ
murin
fibroblast
becam
suscept
transfect
complementari
dna
encod
human
aminopeptidas
n
contrast
infect
human
cell
inhibit
antibodi
rb
express
aminopeptidas
n
enhanc
replic
mous
cell
mutant
aminopeptidas
lack
catalyt
site
enzym
bind
rb
render
murin
cell
suscept
infect
suggest
virusbind
site
may
lie
near
activ
site
human
aminopeptidas
molecul
develop
monoclon
antibodi
receptor
produc
hybridoma
deoxycholatesolubil
membran
protein
two
human
cell
line
lung
fibroblast
myeloid
leukaemia
cell
monoclon
antibodi
design
rb
protect
rd
human
cell
line
cytopath
effect
protect
cell
viru
infect
fig
lac
rb
pretreat
reduc
number
cell
h
postinfect
compar
cell
pretreat
control
mous
ascit
contrast
rb
inhibit
replic
rd
cell
indic
receptor
specif
differ
suscept
infect
mousehuman
somat
cell
hybrid
depend
gene
locat
human
chromosom
ref
promis
candid
hcv
human
coronavirus
hcv
two
serogroup
repres
import
caus
upper
respiratori
tract
infect
report
human
aminopeptidas
n
cellsurfac
metalloproteas
intestin
lung
kidney
epitheli
receptor
human
coronaviru
strain
monoclon
antibodi
rb
block
viru
infect
human
lung
fibroblast
immunoprecipit
aminopeptidas
n
inhibit
enzymat
activ
murin
fibroblast
becam
suscept
transfect
complementari
dna
encod
human
aminopeptidas
n
contrast
infect
human
cell
inhibit
antibodi
rb
express
aminopeptidas
n
enhanc
replic
mous
cell
mutant
aminopeptidas
lack
catalyt
site
enzym
bind
rb
render
murin
cell
suscept
infect
suggest
virusbind
site
may
lie
near
activ
site
human
aminopeptidas
molecul
develop
monoclon
antibodi
receptor
produc
hybridoma
deoxycholatesolubil
membran
protein
two
human
cell
line
lung
fibroblast
myeloid
leukaemia
cell
monoclon
antibodi
design
rb
protect
rd
human
cell
line
cytopath
effect
protect
cell
viru
infect
fig
lac
rb
pretreat
reduc
number
cell
h
postinfect
compar
cell
pretreat
control
mous
ascit
contrast
rb
inhibit
replic
rd
cell
indic
receptor
specif
differ
suscept
infect
mousehuman
somat
cell
hybrid
depend
gene
locat
human
chromosom
ref
promis
candid
hcvii
correspond
address
bind
antibodi
hapn
mut
cell
measur
flow
cytometri
outlin
legend
fig
mutant
lack
peptidas
activ
thu
assay
chemic
inhibit
applic
na
confluent
monolay
cell
plate
pretreat
dilut
antibodi
inhibitor
medium
h
challeng
x
pfu
per
well
h
adsorpt
inoculum
remov
cell
incub
fresh
medium
contain
antibodi
inhibitor
h
time
mdnolay
examin
virusinduc
cytopath
effect
effect
evid
control
pretreat
normal
serum
mockinfect
control
plu
sign
cytopath
effect
inhibit
antibodi
dilut
incub
inhibitor
test
follow
concentr
bestatin
mg
mm
dipyridyl
mm
actinonin
mm
antibodi
test
concentr
satur
avail
bind
site
flow
cytometr
assay
exopeptidas
remov
aminotermin
residu
complet
digest
short
peptid
gut
help
break
neurotransmitt
peptid
brain
hapn
ident
glycoprotein
identifi
granulocyt
monocyt
bone
marrow
progenitor
porcin
aminopeptidas
n
receptor
transmiss
gastroenter
viru
porcin
corona
viru
serogroup
ref
aminopeptidas
human
pig
mammal
structur
similar
investig
whether
rb
would
bind
specif
hapn
whether
express
hapn
murin
cell
would
make
suscept
infect
murin
cell
transfect
hapn
cdna
retrovir
vector
untransfect
cell
chaueng
determin
suscept
viru
infect
although
control
cell
resist
infect
fig
id
hapntransfect
mous
cell
suscept
infect
viru
fig
ie
contrast
cell
suscept
cell
infect
data
shown
thu
express
hapn
confer
suscept
suscept
murin
cell
analys
bind
rb
membran
prepar
parent
fibroblast
antibodi
bound
membran
cell
fig
indic
rb
recogn
hapn
similarli
virion
bound
strongli
membran
membran
fig
rb
competit
inhibit
viru
bind
membran
fig
suggest
rb
may
recogn
adjac
overlap
epitop
peptidas
antibodi
bind
extracellular
epitop
hapn
inhibit
enzymat
activ
compar
abil
rb
inhibit
enzymat
activ
hapn
hybridoma
supernat
test
abil
inhibit
infect
cell
one
rb
posit
rb
hybridoma
subclon
three
time
ascit
fluid
produc
cell
balbc
mice
use
sourc
antibodi
cell
grown
coverslip
pretreat
h
dilut
rb
control
ascit
control
medium
challeng
x
pfu
cell
incub
ac
h
ac
h
df
fix
cold
aceton
antisera
remain
plate
throughout
experi
intracellular
antigen
detect
goat
rhodaminelabel
rabbit
antigoat
immunoglobulin
specif
antibodi
wmi
rb
block
hapn
activ
effici
wmi
better
fig
flow
cytometr
result
indic
rb
bound
cell
fig
b
untransfect
cell
rb
also
immunoprecipit
matur
hapn
glycoprotein
intracellular
precursor
measur
enzymat
activ
intact
cell
x
cell
wash
pb
resuspend
isoton
defin
medium
mm
phosphat
buffer
ph
incub
h
excess
rb
upcio
control
mous
myeloma
protein
incub
still
ac
apn
substrat
alaninepnitroanilin
ad
final
concentr
mm
sampl
period
remov
chill
arrest
enzymat
activ
centrifug
free
pnitroanilin
present
cellfre
supernat
detect
absorb
measur
nm
degrad
substrat
absenc
cell
time
period
minim
measur
made
triplic
cell
data
shown
rb
bind
cell
transfect
cdna
encod
mutant
hapn
glycoprotein
hapn
mut
fig
lack
region
amino
acid
includ
hisgluxxhi
sequenc
mediat
zinc
bind
catalyt
activ
seri
relat
metalloproteas
ls
bound
hapn
mut
cell
fig
confirm
express
mutant
protein
cell
surfac
hapn
mut
cell
suscept
infect
fig
indic
rb
recogn
epitop
elimin
alter
mutant
polypeptid
investig
whether
abil
antibodi
block
infect
correl
abil
block
enzymat
activ
bind
mutant
hapn
polypeptid
rb
block
enzym
activ
viru
infect
fail
bind
hapn
mut
cell
tabl
contrast
although
also
inhibit
infect
partial
inhibit
enzym
activ
recogn
mutant
hapn
glycoprotein
infect
cell
prevent
either
actinonin
bestatin
small
inhibitori
molecul
bind
competit
activ
site
hapn
contrast
infect
inhibit
dipyridyl
block
aminopeptidas
n
activ
cheiat
zinc
requir
enzymat
activ
hapn
molecuj
ls
chelat
may
alter
conform
shown
human
coronaviru
use
human
aminopeptidas
n
receptor
antibodi
direct
activ
site
enzym
prevent
viru
infect
human
cell
serolog
unrel
human
respiratori
corona
viru
use
hapn
receptor
receptor
unknown
relat
murin
coronaviru
whose
receptor
member
carcinoembryon
antigen
famili
glycoprotein
immunoglobulin
superfamili
thu
two
relat
coronavirus
tgey
use
aminopeptidas
n
glycoprotein
normal
host
speci
receptor
wherea
two
coronavirus
differ
serogroup
use
aminopeptidas
receptor
possibl
coronavirus
relat
canin
felin
coronavirus
also
use
receptor
aminopeptidas
relat
metalloproteas
aminopeptidas
ref
neutral
endopeptidas
abund
apic
surfac
epitheli
cell
alimentari
respiratori
tract
metalloproteas
promlsmg
candid
receptor
group
mammalian
virus
bacteria
fungi
